Vertical / Wellness Tech Makers
We grow demand for category-defining wellness tech, from HBOT chambers and cold plunges to PEMF, cryo, and recovery wearables
Raging Agency runs B2B demand generation for wellness technology manufacturers selling HBOT chambers, cold plunge systems, PEMF devices, red light therapy panels, cryotherapy equipment, and recovery wearables into clinical and longevity channels. The typical device price runs $10,000 to $400,000 per unit with 90 to 360 day sales cycles to med spas, surgery centers, hospitals, longevity clinics, and biohacking studios. This page is for manufacturers and distributors selling to the clinical and studio channel. Consumer wellness tech brands selling DTC should see our wellness device consumer marketing page.
Book your free Strategy Call
What wellness tech manufacturer marketing involves
Wellness tech manufacturer marketing for the B2B clinical and longevity channel combines digital paid media on Meta and Google targeting clinic operators, studio owners, and procurement decision-makers; trade show capture at UHMS, A4M, AmSpa, CES Health, and Biohacker Summit; dealer and distributor channel enablement (co-branded landing pages, dealer-specific creative, ROI calculators, demo equipment programs, financing partner integrations); clinical credibility content for SEO and AEO; and a compliance review against the FDA's General Wellness Policy and, where applicable, 510(k) clearance marketing rules.
The sales cycle for clinical buyers runs 90 to 360 days. The funnel design has to support multi-stakeholder decisions (operator, medical director, procurement, finance) with different content and different CTAs at each stage. See our HBOT clinic marketing, biohacking studio marketing, and wellness ad compliance guide for the end-market context.
The General Wellness Policy explainer (FDA 2026 update)
The FDA General Wellness Policy (2019) governs what wellness device makers can claim without triggering medical device regulation. The policy defines the line between wellness claims and medical claims across HRV, oxygen, glucose, and temperature monitoring categories.
A wellness HRV claim ("supports awareness of recovery patterns") is permissible under the policy. A medical HRV claim ("diagnoses autonomic dysfunction") converts the device into a regulated medical product. The same line applies to oxygen monitors (SpO2 awareness vs. hypoxia diagnosis), continuous glucose monitors used outside diabetes management (metabolic awareness vs. glucose disorder treatment), and temperature wearables (recovery tracking vs. fever diagnosis).
Devices with FDA 510(k) clearances can market the specific cleared indications with proper substantiation. HBOT chambers cleared for wound care, decompression sickness, and the other 13 cleared indications can promote those indications. Marketing for off-label longevity and recovery use must use General Wellness Policy language. Wellness tech makers operating across this line need claim language reviewed against the General Wellness Policy before any campaign launches.
Brands we benchmark against
The wellness tech device category is anchored by category-defining brands that have reset consumer and clinical expectations on hardware quality, app experience, and clinical positioning. Wearables and rings: Oura, Whoop, Apollo Neuro, Pulsetto. Sleep and recovery hardware: Eight Sleep, Therabody, Hyperice. Cold plunge and contrast: Plunge, Renu Therapy. Red light and photobiomodulation: Joovv, Higher Dose, BIOMAX, BON CHARGE. Hyperbaric chambers: AmMortal Chamber and the broader HBOT clinical category. PEMF: Pulse Centers, BEMER.
Wellness device makers benchmark against these brands not to copy their positioning but to understand the clinical or consumer buyer's reference point when comparing a new device against the established category leaders. Marketing built to compete in this space respects the buyer's existing brand literacy and clinical credibility expectations.
B2B buyer economics by clinical segment
Each clinical buyer segment has a different price tolerance, sales cycle, and decision-making structure. Med spa operators buy at the lower end of the clinical range with faster cycles because they are business owners making their own capital decisions. Surgery centers and hospitals run multi-stakeholder procurement with longer cycles but higher unit prices. Longevity clinics and concierge buyers prioritize custom install and premium service over price.
Cost per acquired customer for B2B clinical deals typically runs 8 to 15% of first-purchase revenue depending on segment. The $7M HBOT case study referenced in our blog produced a 5.8x ROAS by month 24 at those economics.
Dealer and distributor channel marketing
Wellness tech device makers sell through dealer and distributor channels as much as through direct digital. Trade show capture (Wellness Summit, CES Health, Biohacker Summit, A4M annual meeting) drives a meaningful portion of B2B pipeline. Demo-to-PO conversion runs longer than DTC cycles -- 90 to 180 days for med spa and clinic buyers, 30 to 60 days for prosumer dealer buyers.
Dealer enablement includes co-branded landing pages, dealer-specific creative libraries, ROI calculators for clinic and studio buyers, financing partner integrations (Truemed for HSA/FSA eligibility, equipment lease partners for clinical channel), demo equipment lending programs, and quarterly dealer training. Wellness tech makers without a dealer enablement layer leave revenue on the table because dealers cannot effectively sell the device without manufacturer-produced sales assets. Strong dealer enablement typically scales channel revenue 2 to 4x what unsupported dealer relationships produce.
Clinical credibility content for SEO and AEO
Clinical and longevity buyers research extensively before committing to a $25,000 to $400,000 capital purchase. The content engine that supports that research cycle ranks in Google search, appears in AI answer engines (ChatGPT Search, Perplexity, Google AI Overview), and serves as sales enablement for the dealer and direct sales team. The required signals for AI answer engine citation: direct-answer-first H2 sections, named entity grounding (specific device brands, cleared indications, clinical protocols), sourced statistics, FAQPage schema, and citation-ready 40 to 100 word standalone passages.
Wellness tech manufacturers that invest in clinical credibility content in the first 6 months of a marketing engagement see compounding leverage across SEO, sales enablement, and AEO citation. The content takes 6 months to build but provides leverage across the rest of the engagement.
Frequently asked questions about wellness tech manufacturer marketing
What is wellness tech manufacturer marketing?
Wellness tech manufacturer marketing is B2B demand generation for companies selling wellness equipment (HBOT chambers, cold plunge systems, PEMF devices, red light therapy panels, cryotherapy, recovery wearables) into the clinical and longevity channel. It combines digital paid media targeting clinic operators, trade show capture, dealer and distributor channel enablement, clinical credibility content, and FDA and FTC compliance review. This is distinct from consumer DTC wellness device marketing, which targets end consumers rather than clinical operators.
How does the FDA General Wellness Policy affect wellness device marketing?
The FDA General Wellness Policy (2019) defines the line between wellness claims and medical device claims. Wellness claims ("supports awareness of recovery patterns," "designed to assist with relaxation and recovery") are permissible without triggering medical device regulation. Medical claims ("diagnoses autonomic dysfunction," "treats hypoxia") convert the device into a regulated medical product. Devices with FDA 510(k) clearance can promote their specific cleared indications with proper substantiation. All wellness tech manufacturer marketing must be reviewed against the General Wellness Policy before any campaign launches.
What is dealer enablement for wellness device manufacturers?
Dealer enablement is the set of marketing and sales support assets that lets dealers effectively sell, demo, and service wellness devices without manufacturer involvement on every deal. The components include co-branded landing pages for each dealer, dealer-specific creative libraries, ROI calculators for clinic and studio buyers, demo equipment lending programs, financing partner integration, clinical training materials, and a dedicated dealer success manager at the manufacturer. Strong dealer enablement scales channel revenue 2 to 4x what unsupported dealer relationships produce.
How long does it take to scale a wellness device manufacturer?
Wellness device manufacturer scaling typically requires 18 to 36 months of channel investment to reach meaningful unit volume in US clinical and longevity segments. The first 6 months are foundation building: clinical credibility content, dealer enablement infrastructure, compliance audit, funnel architecture. Months 6 to 12 are channel scaling and dealer expansion. Months 12 to 24 are compounding leverage as referral, dealer, and direct channels mature. The $7M HBOT case study referenced on our blog took 24 months from engagement start, with significant acceleration in months 12 to 24.
How much does wellness tech manufacturer marketing cost?
Pricing varies significantly by device category, distribution model, and US market maturity. Early-stage manufacturers building US market presence typically run $6,000 to $15,000 monthly retainer plus trade show and content investment. Established manufacturers scaling dealer channels and trade show programs run larger monthly engagements. Raging Agency offers performance-based and hybrid plans matched to the B2B sales cycle and unit economics. Final pricing is scoped on a Strategy Call after reviewing the device, channel, and competitive positioning.
Want a wellness device marketing engine that builds B2B pipeline in clinical and longevity channels?
Book a 20-minute Strategy Call.
We will review your device, distribution model, and current channel mix, then quote a plan if it fits.